Drug class in one race
KRAS G12V drugs for Non-Small Cell Lung Cancer
2 tracked KRAS G12V drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the KRAS G12V page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 1/21 Phase 1